Odd Lot Index

THERAGENICS CORP

Odd lots go first

Read automatically from the filing
In a Dutch auction, tendering too high can cost you the priority. The company picks the lowest price that buys the shares it wants, and everyone at or below that price gets it. Tender above it and your shares come back unpurchased — and because you are not in the accepted pool at all, the odd-lot priority never applies. Most offers have a box meaning "accept whatever price is determined", which keeps you in the pool; the trade-off is that you give up any say in the price. The filing explains both.
StatusClosed
Closing date2012-07-11
How it is pricedDutch auction
Odd-lot thresholdFewer than 100 shares
Must tender everything you holdYes
Must tick the odd-lot box on the formYes
Price offeredUSD $2.00 to $2.40 per share, in steps of $0.10
Most an odd-lot tender could be$198.00 to $237.60

Where each of these comes from

Every line above was read out of the filing. Here is the wording it was read from, so you can check it.

election_required = True...res directly to the depositary would not only avoid the payment of brokerage commissions, but also would avoid any applicable odd lot discounts in a sale of the holder’s shares. Any odd lot holder wishing to tender all shares held pursuant to the Offer should complete the section entitled “Odd Lots” in the Letter of Transmittal and, if applicable, in the Notice of Guaranteed Delivery. 2. Purpose of the Offer; Certain Effects of the Offer; Additional Background. Purpose of the Offer We believe that the Offer is a prudent use of our financial resources given our current business and assets. Further, we believe that the Offer is an efficient means to provide value...
expiry = 2012-07-11...MON STOCK FOR AN AGGREGATE PURCHASE PRICE OF $10 MILLION AT A PURCHASE PRICE NOT LESS THAN $2.00 PER SHARE NOR GREATER THAN $2.40 PER SHARE IN A MODIFIED DUTCH AUCTION THE OFFER AND WITHDRAWAL RIGHTS EXPIRE AT 5:00 P.M., NEW YORK TIME, ON JULY 11, 2012, UNLESS THE OFFER IS EXTENDED Theragenics Corporation: ● Is offering to purchase up to 5,000,000 shares of our common stock in a tender offer (the “Offer”), or such lesser number of shares as are properly tendered and not properly withdraw...
listed = True...ly the price of the security prevailing on the New York Stock Exchange (“NYSE”), which may prohibit the trustee from following participant directions to tender shares to Theragenics at certain prices within the offered range. Our common stock: ● Is listed and traded on the NYSE under the symbol “TGX”; and ● Had a closing price of $1.76 on June 11, 2012, the last trading day prior to the announcement of the Offer. We urge you to obtain current market quotations for the shares. The Offer is not conditioned on any minimum number of shares being tendered or the receipt of financing. The Offer is, however, subject t...
mechanism = DUTCH...(1)(A) 2 ex99-a1a.htm EXHIBIT (A)(1)(A) ex99-a1a.htm Exhibit (a)(1)(A) OFFER TO PURCHASE FOR CASH SHARES OF ITS COMMON STOCK FOR AN AGGREGATE PURCHASE PRICE OF $10 MILLION AT A PURCHASE PRICE NOT LESS THAN $2.00 PER SHARE NOR GREATER THAN $2.40 PER SHARE IN A MODIFIED DUTCH AUCTION THE OFFER AND WITHDRAWAL RIGHTS EXPIRE AT 5:00 P.M., NEW YORK TIME, ON JULY 11, 2012, UNLESS THE OFFER IS EXTENDED Theragenics Corporation: ● Is offering to purchase up to 5,000,000 shares of our common stock in a tender offer (the “Offer”), or such lesser number of shares as are properly tendered and not properly withdrawn; and ● Is off...
mechanism = DUTCH...Preliminary Results of Dutch Auction Tender Offer BUFORD, GA. — July 12, 2012 — Theragenics Corporation® (NYSE: TGX), a medical device company serving the surgical products and prostate cancer treatment markets, today announced the preliminary results of its modified “Dutch Auction” tender offer to purchase up to $10 million of its common stock, which expired at 5:00 p.m., New York time, on July 11, 2012. Based on the preliminary count by the depositary for the tender offer, a total of 7,119,345 shares of Theragenics’ common stock were tendered properly and not withdrawn properly at or below the expected purchase p...
mechanism = DUTCH...cs Announces Final Results of Dutch Auction Tender Offer BUFORD, Ga. — July 17, 2012 — Theragenics Corporation® (NYSE: TGX), a medical device company serving the surgical products and prostate cancer treatment markets, today announced the final results of its modified “Dutch Auction” tender offer to purchase up to $10 million of its common stock, which expired at 5:00 p.m., New York time, on July 11, 2012. In accordance with the terms and conditions of the offer, Theragenics has accepted for purchase 4,761,904 shares of its common stock at a purchase price of $2.10 per share, for a total cost of approximately $10 mi...
must_tender_all = True...shares conditionally tendered at or below the Selected Price for which the condition was not initially satisfied, to the extent feasible, by random lot (to be eligible for purchase by random lot, stockholders whose shares are conditionally tendered must have tendered all of their shares). See Sections 1, 3 and 6. If I own fewer than 100 shares and I tender all of my shares, will I be subject to proration? No. If you properly tender (at or below the Selected Price), and do not properly withdraw your shares according to the procedures specified for holders of “odd lots,” we will purchase all of your shares without subject...
price = USD 2.0-2.4...5,000,000 shares of its outstanding common stock or such lesser number of shares as are properly tendered and not withdrawn. See Section 1. What will be the purchase price? ● The price range for the Offer is $2.00 to $2.40 per share. We are conducting the Offer through a procedure commonly called a “modified Dutch auction.” This procedure allows you to choose a price (in increments of $0.10 per share) within this price range at which you...
price = USD 2.1...y count by the depositary for the tender offer, a total of 7,119,345 shares of Theragenics’ common stock were tendered properly and not withdrawn properly at or below the expected purchase price of $2.10 per share. In accordance with the terms and conditions of the offer, and based on the preliminary count by the depositary, Theragenics expects to accept for payment an aggregate of 4,761,904 shares of its common stock at a purcha...
price = USD 2.1...00 p.m., New York time, on July 11, 2012. In accordance with the terms and conditions of the offer, Theragenics has accepted for purchase 4,761,904 shares of its common stock at a purchase price of $2.10 per share, for a total cost of approximately $10 million, excluding fees and expenses related to the tender offer. The 4,761,904 shares accepted for purchase in the tender offer represent approximately 13.7% of Theragenics’ curre...
priority = True...having an aggregate value in excess of $10 million, measured at the maximum price at which such shares were properly tendered, have been properly tendered and not properly withdrawn on or prior to the expiration date, we will purchase shares in the following order of priority: ● first, all shares owned in “odd lots” (fewer than 100 shares) that have been properly tendered at or below the Selected Price; ● second, all other tendered shares (including shares issued upon the exercise of Options and tendered in accordance with the special procedures described in Section 3 and shares in the 401(k) Plan, subject to acceptance in the Offer; but not including conditionally...
threshold = 100...on, measured at the maximum price at which such shares were properly tendered, have been properly tendered and not properly withdrawn on or prior to the expiration date, we will purchase shares in the following order of priority: ● first, all shares owned in “odd lots” (fewer than 100 shares) that have been properly tendered at or below the Selected Price; ● second, all other tendered shares (including shares issued upon the exercise of Options and tendered in accordance with the special procedures described in Section 3 and shares in the 401(k) Plan, subject to acceptance in the Offer; but not including conditionally tender...
txn_type = TENDER_OFFEREX-99.(A)(1)(A) 2 ex99-a1a.htm EXHIBIT (A)(1)(A) ex99-a1a.htm Exhibit (a)(1)(A) OFFER TO PURCHASE FOR CASH SHARES OF ITS COMMON STOCK FOR AN AGGREGATE PURCHASE PRICE OF $10 MILLION AT A PURCHASE PRICE NOT LESS THAN $2.00 PER SHARE NOR GREATER THAN $2.40 PER SHARE IN A MODIFIED DUTCH AUCTION THE OFFER AND WITHDRAWAL RIGHTS EXPIRE AT 5:00 P.M., NEW YORK TIME, ON JULY 11, 2012, UNLESS THE OFFER IS EXTENDED Theragenics Corporation: ● Is...
txn_type = TENDER_OFFER...and supplements the Tender Offer Statement on Schedule TO (“Schedule TO”) originally filed with the United States Securities and Exchange Commission by Theragenics Corporation (“Theragenics” or the “Company”) on June 12, 2012, in connection with the Company’s offer to purchase shares of its common stock, par value $0.01, for an aggregate purchase price of up to $10 million, at a price not less than $2.00 or greater than $2.40 per share, to the seller in cash, without interest, upon the terms and subject to the conditions set forth in the Offer to Purchase. This Amendment No. 1 is intended to satisfy the report...
txn_type = TENDER_OFFER...ction Tender Offer BUFORD, GA. — July 12, 2012 — Theragenics Corporation® (NYSE: TGX), a medical device company serving the surgical products and prostate cancer treatment markets, today announced the preliminary results of its modified “Dutch Auction” tender offer to purchase up to $10 million of its common stock, which expired at 5:00 p.m., New York time, on July 11, 2012. Based on the preliminary count by the depositary for the tender offer, a total of 7,119,345 shares of Theragenics’ common stock were tendered properly and not withdrawn properly at or below the expected purchase price of $2.10 per share. I...
txn_type = TENDER_OFFER...tch Auction Tender Offer BUFORD, Ga. — July 17, 2012 — Theragenics Corporation® (NYSE: TGX), a medical device company serving the surgical products and prostate cancer treatment markets, today announced the final results of its modified “Dutch Auction” tender offer to purchase up to $10 million of its common stock, which expired at 5:00 p.m., New York time, on July 11, 2012. In accordance with the terms and conditions of the offer, Theragenics has accepted for purchase 4,761,904 shares of its common stock at a purchase price of $2.10 per share, for a total cost of approximately $10 million, excluding fees and...

The filings

FiledFormRoleOn EDGAR
2012-06-12SC TO-Ioriginal (governing)View
2012-06-22SC TO-I/AamendmentView
2012-07-12SC TO-I/AamendmentView
2012-07-18SC TO-I/AamendmentView